title: Optical coherence tomography follow-up after bioresorbable in metallic and metallic in bioresorbable stenting: tackling in-stent restenosis in the era of bioresorbable vascular scaffolds.
authors.affiliation: Department of Cardiology, University Heart Center, University Hospital Zürich, Rämistrasse 100, Zürich CH 8091, Switzerland.
authors.forename: Antonio H
authors.initials: AH
authors.lastname: Frangieh
authors.affiliation: Department of Cardiology, University Heart Center, University Hospital Zürich, Rämistrasse 100, Zürich CH 8091, Switzerland.
authors.forename: Christian
authors.initials: C
authors.lastname: Templin
authors.affiliation: Department of Cardiology, University Heart Center, University Hospital Zürich, Rämistrasse 100, Zürich CH 8091, Switzerland ronald.binder@usz.ch.
authors.forename: Ronald K
authors.initials: RK
authors.lastname: Binder
mesh_terms: D020341:Absorbable Implants; D000787:Angina Pectoris / Q000601:surgery; D023921:Coronary Stenosis / Q000601:surgery; D054855:Drug-Eluting Stents; D000068338:Everolimus / Q000008:administration & dosage; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D008670:Metals; D008875:Middle Aged; D062645:Percutaneous Coronary Intervention; D012008:Recurrence; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D054457:Tissue Scaffolds; D041623:Tomography, Optical Coherence; D050257:Tubulin Modulators / Q000008:administration & dosage
chemical_list: D008670:Metals; D050257:Tubulin Modulators; D000068338:Everolimus; C489443:zotarolimus; D020123:Sirolimus